SETBP1 and chronic myelogenous leukemia, BCR-ABL1 positive: SETBP1 was reported to be highly expressed in a subset of AML [20] and CML patients with blast crisis [23], and promoted leukemogenesis by inhibiting tumor suppressor gene PP2A [31].